Sinovac has already shipped some 380 mn doses, more than AstraZeneca and second only to Pfizer, worldwide. But it still hasn’t published any data in an academic journal.
Indonesia tracked 25,374 health workers in Jakarta for 28 days after receiving their second dose. Health Minister Budi Gunadi said 94% of them had been vaccinated.
Demand is expected to rise if WHO authorises China’s Sinovac & Sinopharm vaccines, allowing developing countries in Asia, Africa & Latin America to access them through Covax.
Vastly different efficacy rates in 4 clinical trial sites raised concerns over whether Sinovac, that’s key to vaccine drives in some of the world's hotspots, will be effective.
The vaccine was found to be about 65% effective against Covid in late stage-trials in the city of Bandung. The emergency use approval is the first for Sinovac’s shot outside of China.
The protection rate, confirmed by Sao Paulo state officials, was derived from Sinovac’s most advanced final-phase trials in Brazil involving about 13,000 participants.
The current Iran war has laid bare a fundamental reality: 20 per cent of global energy trade cannot afford to rely on a single artery, no matter how resilient and cost-effective.
Regulator seeks feedback on allowing firms to repurchase shares via exchanges after tax changes, as markets reel from war-led selloff and foreign outflows.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS